The downregulation of FOXA2, DHTKD1 and CDH1, involved in embryonic development, oxidation reactions and intercellular adhesions, respectively, were also linked to worse prognosis of NSCLC patients in our study. Here, FOXA2 is linked to non-small cell lung carcinoma.